Search

Your search keyword '"Olmos G"' showing total 256 results
Start Over Author "Olmos G"
256 results on '"Olmos G"'

2. NUEVO CORONAVIRUS (COVID-19) EN POBLACIÓN GENERAL Y PEDIÁTRICA: UNA REVISIÓN EPIDEMIOLÓGICA. CHILE 2020. NOVEL CORONAVIRUS (COVID-19) IN GENERAL AND PEDIATRIC POPULATION: AN EPIDEMIOLOGICAL REVIEW. CHILE 2020.

Author

Claudio Olmos G., Javier Cepeda S., and Daniel Zenteno A.

Subjects
covid-19, epidemiología, niños, Pediatrics, RJ1-570
Abstract

A partir de diciembre del 2019, se ha reportado el brote de una nueva infección por SARS Cov-2 en Wuhan, China. Actualmente, la enfermedad por el nuevo coronavirus 2019 ha alcanzado el estatus de pandemia. El reporte de casos en pacientes pediátricos ha sido escaso. El objetivo de este artículo es entregar información epidemiológica del COVID-19, especialmente pediátrica. Los niños han presentado enfermedad en clusters, secundaria a contacto con parientes enfermos. La clínica es oligosintomática, menos severa y mayor riesgo concentrado en menores de 1 año y con comorbilidad. En Chile, los pacientes pediátricos representan cerca del 6% del total y la letalidad global es notablemente más baja que en adultos. Las principales medidas de control para la reducción de la reproducción efectiva son el testeo masivo, distanciamiento social y cierre escolar, sin desestimar la responsabilidad individual. El adecuado abastecimiento de elementos de protección personal es clave para evitar la infección nosocomial y del personal de salud.

Published
2020
Full Text
View/download PDF

19. Introducing the Gab Hate Corpus: Defining and applying hate-based rhetoric to social media posts at scale

Author

Mohammad Atari, Gwenyth Portillo-Wightman, Kim Y, Park C, Joe Hoover, Brendan F. Kennedy, Shreya Havaldar, Leigh Yeh, Wang C, Morteza Dehghani, Hussain A, Wang X, Coombs K, Aida Mostafazadeh Davani, olmos g, Lara A, Elaine Gonzalez, Ali Omrani, Omary A, Zhang Y, and Azatian A

Subjects
business.industry, Artificial intelligence, Psychology, computer.software_genre, business, computer, Natural language processing
Abstract

We present the Gab Hate Corpus (GHC), consisting of 27,665 posts from the social network service gab.com, each annotated for the presence of “hate-based rhetoric” by a minimum of three annotators. Posts were labeled according to a coding typology derived from a synthesis of hate speech definitions across legal precedent, previous hate speech coding typologies, and definitions from psychology and sociology, comprising hierarchical labels indicating dehumanizing and violent speech as well as indicators of targeted groups and rhetorical framing. We provide inter-annotator agreement statistics and perform a classification analysis in order to validate the corpus and establish performance baselines. The GHC complements existing hate speech datasets in its theoretical grounding and by providing a large, representative sample of richly annotated social media posts.

Published
2018

26. Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons

Author

Lladó J, Tolosa L, and Olmos G

Subjects
nervous system, ALS, AMPA receptors, Akt, VEGF, excitotoxicity, motoneuron
Abstract

Vascular endothelial growth factor (VEGF), originally described as a factor with a regulatory role in vascular growth and development, it is also known for its direct effects on neuronal cells. The discovery in the past decade that transgenic mice expressing reduced levels of VEGF developed late-onset motoneuron pathology, reminiscent of amyotrophic lateral sclerosis (ALS), opened a new field of research on this disease. VEGF has been shown to protect motoneurons from excitotoxic death, which is a relevant mechanism involved in motoneuron degeneration in ALS. Thus, VEGF delays motoneuron degeneration and increases survival in animal models of ALS. VEGF exerts its anti-excitotoxic effects on motoneurons through molecular mechanisms involving the VEGF receptor-2 resulting in the activation of the PI3-K/Akt signaling pathway, upregulation of GluR2 subunit of AMPA receptors, inhibition of p38MAPK, and induction of the anti-apoptotic molecule Bcl-2. In addition, VEGF acts on astrocytes to reduce astroglial activation and to induce the release of growth factors. The potential use of VEGF as a therapeutic tool in ALS is counteracted by its vascular effects and by its short effective time frame. More studies are needed to assess the optimal isoform, route of administration, and time frame for using VEGF in the treatment of ALS.

Published
2013

27. Alternativas de pastoreo para el ganado ovino de carne en zonas de secano

Author

Olmos, G., Valiente, O.L., Delgado Enguita, Ignacio, Vega, A. de, and Guada, J.A.

Subjects
producción y sanidad animal, Sistemas de pastoreo, Plantas forrajeras, Zona árida, GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries), Pastizales, Ovinos
Abstract

Published

Published
2012

28. Pâturage: une alternative pour la cultures d’orge à faible rendement

Author

Olmos, G., Keli, A., Vega, A. de, Delgado Enguita, Ignacio, and Guada, J.A.

Subjects
Grain vitreux, Ovins, Grazing, Valor nutritivo, Vitreous grain, Sheep, Producción y sanidad animal, Barley, Pastoreo, Orge, Pâturage, Cebada, Ovinos
Abstract

An experiment was performed to evaluate the nutritive value of vitreous-grain barley grazed by sheep (instantaneous stocking rate of 66 sheep/ha). Available biomass (2353 kg dry matter (DM)/ha, on average) was determined at the beginning of the experimental period, which lasted for three consecutive weeks, and barley heads, leaves and stems were separated for quantification. Important amounts of Wimmera ryegrass (Lolium rigidum) were also found. Diet selection, intake and digestibility were estimated using the nalkanes technique. Rumen fermentation characteristics and in situ degradation parameters were obtained from rumen cannulated animals. Transit kinetics of barley heads, leaves and stems was also assessed. The proportion of barley heads in the diet consumed was high (0.53 on average) and varied along the grazing period (0.30 in the first, 0.64 in the second and 0.65 in the third week). Wimmera ryegrass was highly selected during the first week of the experimental period (0.7) and much lesser afterwards (0.35). Estimated total DM intake was low (428, 376 and 657 g/day for weeks 1, 2 and 3, respectively), and chan ged with the botanical composition of the paddock and biomass availability. Average DM digestibility of the diet consumed was also low (56%) and decreased as the grazing period advanced (67%, 55% and 47% for weeks 1, 2 and 3, respectively). Rumen pH was, on average, 6.6, whereas ammonia concentration reached a value of 93 mg/l. Proportions of acetic (0.65), propionic (0.15) and butyric (0.15) acids were representative of a rumen environment driven by fibre fermentation. Effective DM degradability of barley heads, leaves and stems was, on average, 81%, 66% and 55%, respectively. Un essai a été mené pour évaluer la valeur nutritive de l’orge en stade de grain vitreux pâturé par les ovins (taux de charge animale instantanée de 66 brebis/ha). La biomasse disponible (2353 kilogrammes de matière sèche (MS)/ha, en moyenne) a été déterminée au début de la période expérimentale, qui a duré trois semaines consécutives, et les épis, les feuilles et les tiges de l’orge ont été séparés pour leur quantification. Des quantités importantes d’ivraie raide (Lolium rigidum) ont été également rencontrées. Le choix alimentaire, les quantités ingérées et la digestibilité du régime ont été estimés en utilisant la technique des nalcanes. Les caractéristiques de fermentation ruminale et les paramètres de dégradation in situ ont été obtenues en utilisant des animaux canulés dans le rumen. La cinétique de passage des épis, des feuilles et des tiges d’orge a été également évaluée. La proportion des épis d’orge dans le régime consommé était élevée (0,53 en moyenne) et variait le long de la période de pâturage (0,30, 0,64 et 0,65 pendant la première, la deuxième et la troisième semaine respectivement). L’ivraie raide a été fortement choisie pendant la première semaine de la période expérimentale (0,7) et beaucoup moins après (0,35). Les quantités ingérées estimées de MS étaient faibles (428, 376 et 657 g/j pendant la 1ère, 2ème et 3ème semaine, respectivement), et changeaient avec la composition botanique et la disponibilité de la biomasse. La digestibilité moyenne de MS du régime consommé était également faible (56%) et diminuait avec la progression de la période du pâturage (67%, 55% et 47% durant la 1ère, 2ème et 3ème semaine, respectivement). Le pH ruminal était, en moyenne, de 6,6, tandis que la concentration en ammoniaque atteignait une valeur 93 de mg/l. Les proportions d’acide acétique (0,65), propionique (0,15) et butyrique (0,15) étaient représentatives d’un milieu ruminal propice d’une fermentation cellulolytique. La dégradabilité effective de la MS des épis, des feuilles et des tiges d‘orge était, en moyenne, 81%, 66% et 55%, respectivement.

Published
2011

30. Evaluation of Estrus Detection Efficacy and Accuracy by Three Methods in a Confinement or Pasture Management System with Holstein-Friesian Cows

Author

Mee, J. F., Palmer, M. A., Olmos, G., and Boyle, L. A.

Abstract

Unlike some dairy industries where synchronization of estrus and ovulation is commonly practiced, dairy producers in Ireland rely on visual observation to detect spontaneous estrus in order to plan timing of artificial insemination (AI). A recent survey found that 59% of dairy producers using AI use estrus detection aids. Tail paint (93.9%) is the most commonly used aid (vasectomized bull 4%, Kamars 0.7%, other 1.4%). Though the majority of cows are bred at pasture, a minority of the national herd is bred while housed. The objective of this experiment was to compare the efficacy of three methods of estrus detection in two management systems., American Association of Bovine Practitioners Proceedings of the Annual Conference, 2008

Published
2008
Full Text
View/download PDF

31. Cow welfare in grass based milk production systems

Author

Boyle, Laura, Olmos, G., Llamas Moya, S., Palmer, M.A., Gleeson, David E, O'Brien, Bernadette, Horan, Brendan, Berry, Donagh P., Arkins, S., Alonso Gómez, M., and Mee, John F

Subjects
genetic selection, Irish Economic Breeding Index (EBI), food and beverages, Dairy Cow Welfare, pasture based milk production systems
Abstract

End of project report Under this project, aspects of pasture based milk production systems, namely different milking frequency and feeding strategies as well as genetic selection for improved fitness using the Irish Economic Breeding Index (EBI) were evaluated in terms of dairy cow behaviour, health, immune function and reproductive performance. Additionally, a typical Irish pasture based system was compared to one in which cows were kept indoors in cubicles and fed a total mixed ration for the duration of lactation in order to elucidate the perceived benefits of pasture based systems for dairy cow welfare.

Published
2008

32. [Clinical correlation of hypnagogic hypersynchrony during sleep in normal children and those with learning disability]

Author

G, Olmos G de Alba, M I, Fraire-Martínez, and R, Valenzuela-Romero

Subjects
Learning Disabilities, Humans, Sleep Deprivation, Electroencephalography, Sleep Stages, Child
Abstract

One of the electroencephalographic (EEG) patterns that can be mistaken for paroxysmal clinical activity, when not taken into account and especially in children, is hypnagogic hypersynchrony (HH). This consists in generalised, paroxysmal, synchronic, symmetrical, slow, high voltage waves lasting 2 8 seconds, which appear in drowsiness and in stage I. It was observed that this pattern often appeared in children with learning disability (LD). AIMS. To correlate clinical data with the presence of HH during sleep in normal children and those with LD.We assessed 180 children between the ages of 6 12 years with normal neurological development, 130 of which suffered LD and 50 who did not have LD. EEG was performed with sleep deprivation, following the International Federation of Clinical Neurophysiology guidelines.The presence or absence of HH, together with its characteristics, was assessed. Of the children with LD, 35.38% displayed HH and of the children without LD, only 4% displayed HH. Since the characteristics of HH in the children with LD were different to previous descriptions, we put forward criteria with which to evaluate those differences.HH appeared more often in children with LD than in normal children. Qualitative, quantitative (p0.05) and morphological changes were found in the paroxysmal activity of HH during the stages of sleep in children with LD.

Published
2003

33. [Intravenous treatment with immunoglobulins in epileptic syndromes which are difficult to control]

Author

J, Espinosa Zacarías, J, Gutiérrez Moctezuma, H, Villegas Peña, and G, Olmos G De Alba

Subjects
Male, Epilepsy, Immunoglobulin G, Humans, Immunoglobulins, Intravenous, Infant, Female, Spasms, Infantile
Abstract

Several mechanisms have been found to be involved in the development of malignant epileptic syndromes in childhood and an immunological component has been shown in experimental studies of epilepsy. The effect of intravenous immunoglobulin (IgIV) has been reported in various cases of epilepsy which were difficult to control.To show the usefulness of IgIV in West s syndrome (WS) and Lennox Gastaut syndrome (LGS) which were difficult to control.We selected five patients who fulfilled the criteria for WS and LGS which were difficult to control. They were given IgIV for five days and subsequently six fortnightly doses of 0.5 g/kg/day. We recorded data on sex, age, onset of the disorder and laboratory investigations, including blood and cerebrospinal fluid (CSF) immunoglobulin levels.Four girls with symptomatic WS and one boy with LGS as a symptom of a neuro infection. Treatment was started at the age of 8 14 months. The spasms varied between 204 and 1,074 in 24 hours, and were markedly reduced after IgIV was given. The IgG in the CSF rose as the number of spasms fell (p0.05).There was a satisfactory response to treatment, as reported in previous publications. It is a coadjuvant treatment for cases which are difficult to control and may also be useful in cases of symptomatic epilepsy where goods results are also obtained.

Published
2002

34. Activation of I2-imidazoline receptors enhances supraspinal morphine analgesia in mice: A model to detect agonist and antagonist activities at these receptors

Author

Sánchez-Blázquez, Pilar, Assumpció Boronat, M., Olmos, G., García-Sevilla, A., and Garzón, Javier

Abstract

1. This work investigates the receptor acted upon by imidazoline compounds in the modulation of morphine analgesia. The effects of highly selective imidazoline ligands on the supraspinal antinociception induced by morphine in mice were determined. 2. Intracerebroventricular (i.c.v.) or subcutaneous (s.c.) administration of ligands selective for the I2-imidazoline receptor, 2-BFI, LSL 60101, LSL 61122 and aganodine, and the non selective ligand agmatine, increased morphine antinociception in a dose-dependent manner. Neither moxonidine, a mixed I2-imidazoline and α2-adrenoceptor agonist, RX821002, a potent α2-adrenoceptor antagonist that displays low affinity at I2-imidazoline receptors, nor the selective non-imidazoline α2-adrenoceptor antagonist RS-15385-197, modified the analgesic responses to morphine. 3. Administration of pertussis toxin (0.25 μg per mouse, i.c.v.) 6 days before the analgesic test blocked the ability of the I2-imidazoline ligands to potentiate morphine antinociception. 4. The increased effect of morphine induced by I2-imidazoline ligands (agonists) was completely reversed by idazoxan and BU 224. Identical results were obtained with IBI, which alkylates I2-imidazoline binding sites. Thus, both agonist and antagonist properties of imidazoline ligands at the I2-imidazoline receptors were observed. 5. Pre-treatment (30 min) with deprenyl, an irreversible inhibitor of monoamine oxidase B (IMAO-B), produced an increase of morphine antinociception. Clorgyline, an irreversible IMAO-A, given 30 min before morphine did not alter the effect of the opioid. At longer intervals (24 h) a single dose of either clorgyline or deprenyl reduced the density of I2-imidazoline receptors and prevented the I2-mediated potentiation of morphine analgesia. 6. These results demonstrate functional interaction between I2-imidazoline and opioid receptors. The involvement of G(i)-G(o) transducer proteins in this modulatory effect is also suggested.

Published
2000

35. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor

Author

Olmos, G., Gregorio-Rocasolano, Nuria, Regalado, M. Paz, Gasull, Teresa, Boronat, M. Assumpció, Trullas, Ramón, Villarroel, Álvaro, Lerma Gómez, Juan, and García-Sevilla, A.

Subjects
Cerebellar granule cells, Agmatine, N-methyl-D-aspartate receptors, Imidazoline, Neurotoxicity, Glutamate, Neuroprotection
Abstract

10 páginas, 7 figuras, 1 tabla., This study was designed to assess the potential neuroprotective effect of several imidazol(ine) drugs and agmatine on glutamate-induced necrosis and on apoptosis induced by low extracellular K+ in cultured cerebellar granule cells. Exposure (30 min) of energy deprived cells to L-glutamate (1–100 μM) caused a concentration-dependent neurotoxicity, as determined 24 h later by a decrease in the ability of the cells to metabolize 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) into a reduced formazan product. L-glutamate-induced neurotoxicity (EC50=5 μM) was blocked by the specific NMDA receptor antagonist MK-801 (dizocilpine). Imidazol(ine) drugs and agmatine fully prevented neurotoxicity induced by 20 μM (EC100) L-glutamate with the rank order (EC50 in μM): antazoline (13)>cirazoline (44)>LSL 61122 [2-styryl-2-imidazoline] (54)>LSL 60101 [2-(2-benzofuranyl) imidazole] (75)>idazoxan (90)>LSL 60129 [2-(1,4-benzodioxan-6-yl)-4,5-dihydroimidazole] (101)>RX821002 (2-methoxy idazoxan) (106)>agmatine (196). No neuroprotective effect of these drugs was observed in a model of apoptotic neuronal cell death (reduction of extracellular K+) which does not involve stimulation of NMDA receptors. Imidazol(ine) drugs and agmatine fully inhibited [3H]-(+)-MK-801 binding to the phencyclidine site of NMDA receptors in rat brain. The profile of drug potency protecting against L-glutamate neurotoxicity correlated well (r=0.90) with the potency of the same compounds competing against [3H]-(+)-MK-801 binding. In HEK-293 cells transfected to express the NR1-1a and NR2C subunits of the NMDA receptor, antazoline and agmatine produced a voltage- and concentration-dependent block of glutamate-induced currents. Analysis of the voltage dependence of the block was consistent with the presence of a binding site for antazoline located within the NMDA channel pore with an IC50 of 10–12 μM at 0 mV. It is concluded that imidazol(ine) drugs and agmatine are neuroprotective against glutamate-induced necrotic neuronal cell death in vitro and that this effect is mediated through NMDA receptor blockade by interacting with a site located within the NMDA channel pore., This study was supported by DGICYT Grants PB94-0002-Mod C (J.A. García-Sevilla), PB94-0017 (R. Trullas) and PM-0008/96 (J. Lerma) from the Ministerio de Educación y Cultura.M.A. Boronat was supported by a fellowship from the Universitat de les Illes Balears. We are grateful to Consell Insular de Mallorca for support and to the pharmaceuticals firms for gifts of drugs.

Published
1999

38. Experimental pathology

Author

Yi Chun, D. X., primary, Alexandre, H., additional, Edith, B., additional, Nacera, O., additional, Julie, P., additional, Chantal, J., additional, Eric, R., additional, Zhang, X., additional, Jin, Y., additional, Miravete, M., additional, Dissard, R., additional, Klein, J., additional, Gonzalez, J., additional, Caubet, C., additional, Pecher, C., additional, Pipy, B., additional, Bascands, J.-L., additional, Mercier-Bonin, M., additional, Schanstra, J., additional, Buffin-Meyer, B., additional, Claire, R., additional, Rigothier, C., additional, Richard, D., additional, Sebastien, L., additional, Moin, S., additional, Chantal, B., additional, Christian, C., additional, Jean, R., additional, Migliori, M., additional, Cantaluppi, V., additional, Mannari, C., additional, Medica, D., additional, Giovannini, L., additional, Panichi, V., additional, Goldwich, A., additional, Alexander, S., additional, Andre, G., additional, Amann, K., additional, Migliorini, A., additional, Sagrinati, C., additional, Angelotti, M. L., additional, Mulay, S. R., additional, Ronconi, E., additional, Peired, A., additional, Romagnani, P., additional, Anders, H.-J., additional, Chiang, W. C., additional, Lai, C. F., additional, Peng, W.-H., additional, Wu, C. F., additional, Chang, F.-C., additional, Chen, Y.-T., additional, Lin, S.-L., additional, Chen, Y. M., additional, Wu, K. D., additional, Lu, K.-S., additional, Tsai, T. J., additional, Virgine, O., additional, Qing Feng, F., additional, Zhang, S.-Y., additional, Dominique, D., additional, Vincent, A., additional, Marina, C., additional, Philippe, L., additional, Georges, G., additional, Pawlak, A., additional, Sahali, D., additional, Matsumoto, S., additional, Kiyomoto, H., additional, Ichimura, A., additional, Dan, T., additional, Nakamichi, T., additional, Tsujita, T., additional, Akahori, K., additional, Ito, S., additional, Miyata, T., additional, Xie, S., additional, Zhang, B., additional, Shi, W., additional, Yang, Y., additional, Nagasu, H., additional, Satoh, M., additional, Kidokoro, K., additional, Nishi, Y., additional, Ihoriya, C., additional, Kadoya, H., additional, Sasaki, T., additional, Kashihara, N., additional, Wu, C.-F., additional, Chou, Y.-H., additional, Duffield, J., additional, Rocca, C., additional, Gregorini, M., additional, Corradetti, V., additional, Valsania, T., additional, Bedino, G., additional, Bosio, F., additional, Pattonieri, E. F., additional, Esposito, P., additional, Sepe, V., additional, Libetta, C., additional, Rampino, T., additional, Dal Canton, A., additional, Omori, H., additional, Kawada, N., additional, Inoue, K., additional, Ueda, Y., additional, Yamamoto, R., additional, Matsui, I., additional, Kaimori, J., additional, Takabatake, Y., additional, Moriyama, T., additional, Isaka, Y., additional, Rakugi, H., additional, Wasilewska, A., additional, Taranta-Janusz, K., additional, Deebek, W., additional, Kuroczycka-Saniutycz, E., additional, Lee, A. S., additional, Lee, J. E., additional, Jung, Y. J., additional, Kang, K. P., additional, Lee, S., additional, Kim, W., additional, Arfian, N., additional, Emoto, N., additional, Yagi, K., additional, Nakayama, K., additional, Hartopo, A. B., additional, Nugrahaningsih, D. A., additional, Yanagisawa, M., additional, Hirata, K.-I., additional, Munoz-Felix, J. M., additional, Lopez-Novoa, J. M., additional, Martinez-Salgado, C., additional, Oujo, B., additional, Arevalo, M., additional, Bernabeu, C., additional, Perez-Barriocanal, F., additional, Jesper, K., additional, Nathalie, V., additional, Pierre, G., additional, Yi Chun, D. X., additional, Iyoda, M., additional, Shibata, T., additional, Matsumoto, K., additional, Shindo-Hirai, Y., additional, Kuno, Y., additional, Wada, Y., additional, Akizawa, T., additional, Schwartz, I., additional, Schwartz, D., additional, Prot Bertoye, C., additional, Terryn, S., additional, Claver, J., additional, Beghdadi, W. B., additional, Monteiro, R., additional, Blank, U., additional, Devuyst, O., additional, Daugas, E., additional, Van Beneden, K., additional, Geers, C., additional, Pauwels, M., additional, Mannaerts, I., additional, Van den Branden, C., additional, Van Grunsven, L. A., additional, Seckin, I., additional, Pekpak, M., additional, Uzunalan, M., additional, Uruluer, B., additional, Kokturk, S., additional, Ozturk, Z., additional, Sonmez, H., additional, Yaprak, E., additional, Furuno, Y., additional, Tsutsui, M., additional, Morishita, T., additional, Shimokawa, H., additional, Otsuji, Y., additional, Yanagihara, N., additional, Kabashima, N., additional, Ryota, S., additional, Kanegae, K., additional, Miyamoto, T., additional, Nakamata, J., additional, Ishimatsu, N., additional, Tamura, M., additional, Nakagawa, T., additional, Ichikawa, K., additional, Miyamoto, M., additional, Takabayashi, D., additional, Yamazaki, H., additional, Kakeshita, K., additional, Koike, T., additional, Kagitani, S., additional, Tomoda, F., additional, Hamashima, T., additional, Ishii, Y., additional, Inoue, H., additional, Sasahara, M., additional, El Machhour, F., additional, Kerroch, M., additional, Mesnard, L., additional, Chatziantoniou, C., additional, Dussaule, J.-C., additional, Inui, K., additional, Sasai, F., additional, Maruta, Y., additional, Nishiwaki, H., additional, Kawashima, E., additional, Inoue, Y., additional, Yoshimura, A., additional, Musacchio, E., additional, Priante, G., additional, Valvason, C., additional, Sartori, L., additional, Baggio, B., additional, Kim, J. H., additional, Gross, O., additional, Diana, R., additional, Gry, D. H., additional, Asimal, B., additional, Johanna, T., additional, Imke, S.-E., additional, Lydia, W., additional, Gerhard-Anton, M., additional, Hassan, D., additional, Cano, J. L., additional, Griera, M., additional, Olmos, G., additional, Martin, P., additional, Cortes, M. A., additional, Lopez-Ongil, S., additional, Rodriguez-Puyol, D., additional, DE Frutos, S., additional, Gonzalez, M., additional, Luengo, A., additional, Rodriguez-Puyol, M., additional, Calleros, L., additional, Lupica, R., additional, Lacquaniti, A., additional, Donato, V., additional, Maggio, R., additional, Mastroeni, C., additional, Lucisano, S., additional, Cernaro, V., additional, Fazio, M. R., additional, Quartarone, A., additional, Buemi, M., additional, Kacik, M., additional, Goedicke, S., additional, Eggert, H., additional, Hoyer, J. D., additional, Wurm, S., additional, Steege, A., additional, Banas, M., additional, Kurtz, A., additional, Banas, B., additional, Lasagni, L., additional, Lazzeri, E., additional, Romoli, S., additional, Schaefer, I., additional, Teng, B., additional, Worthmann, K., additional, Haller, H., additional, Schiffer, M., additional, Prattichizzo, C., additional, Netti, G. S., additional, Rocchetti, M. T., additional, Cormio, L., additional, Carrieri, G., additional, Stallone, G., additional, Grandaliano, G., additional, Ranieri, E., additional, Gesualdo, L., additional, Kucher, A., additional, Smirnov, A., additional, Parastayeva, M., additional, Beresneva, O., additional, Kayukov, I., additional, Zubina, I., additional, Ivanova, G., additional, Abed, A., additional, Schlekenbach, L., additional, Foglia, B., additional, Kwak, B., additional, Chadjichristos, C., additional, Queisser, N., additional, Schupp, N., additional, Brand, S., additional, Himer, L., additional, Szebeni, B., additional, Sziksz, E., additional, Saijo, S., additional, Kis, E., additional, Prokai, A., additional, Banki, N. F., additional, Fekete, A., additional, Tulassay, T., additional, Vannay, A., additional, Hegner, B., additional, Schaub, T., additional, Lange, C., additional, Dragun, D., additional, Klinkhammer, B. M., additional, Rafael, K., additional, Monika, M., additional, Anna, M., additional, Van Roeyen, C., additional, Boor, P., additional, Eva Bettina, B., additional, Simon, O., additional, Esther, S., additional, Floege, J., additional, Kunter, U., additional, Janke, D., additional, Jankowski, J., additional, Hayashi, M., additional, Takamatsu, I., additional, Horimai, C., additional, Yoshida, T., additional, Seno DI Marco, G., additional, Koenig, M., additional, Stock, C., additional, Reiermann, S., additional, Amler, S., additional, Koehler, G., additional, Fobker, M., additional, Buck, F., additional, Pavenstaedt, H., additional, Lang, D., additional, Brand, M., additional, Plotnikov, E., additional, Morosanova, M., additional, Pevzner, I., additional, Zorova, L., additional, Pulkova, N., additional, Zorov, D., additional, Wornle, M., additional, Ribeiro, A., additional, Belling, F., additional, Merkle, M., additional, Nakazawa, D., additional, Nishio, S., additional, Shibasaki, S., additional, Tomaru, U., additional, Akihiro, I., additional, Kobayashi, I., additional, Imanishi, Y., additional, Kurajoh, M., additional, Nagata, Y., additional, Yamagata, M., additional, Emoto, M., additional, Michigami, T., additional, Ishimura, E., additional, Inaba, M., additional, Wu, C.-C., additional, Lu, K.-C., additional, Chen, J.-S., additional, Chu, P., additional, Lin, Y.-F., additional, Eller, K., additional, Schroll, A., additional, Kirsch, A., additional, Huber, J., additional, Weiss, G., additional, Theurl, I., additional, Rosenkranz, A. R., additional, Zawada, A., additional, Rogacev, K., additional, Achenbach, M., additional, Fliser, D., additional, Held, G., additional, Heine, G. H., additional, Miyamoto, Y., additional, Iwao, Y., additional, Watanabe, H., additional, Kadowaki, D., additional, Ishima, Y., additional, Chuang, V. T. G., additional, Sato, K., additional, Otagiri, M., additional, Maruyama, T., additional, Iwatani, H., additional, Honda, D., additional, Noguchi, T., additional, Tanaka, M., additional, Tanaka, H., additional, Fukagawa, M., additional, Pircher, J., additional, Koppel, S., additional, Mannell, H., additional, Krotz, F., additional, Virzi, G. M., additional, Bolin, C., additional, Cruz, D., additional, Scalzotto, E., additional, De Cal, M., additional, Vescovo, G., additional, Ronco, C., additional, Grobmayr, R., additional, Lech, M., additional, Ryu, M., additional, Aoshima, Y., additional, Mizobuchi, M., additional, Ogata, H., additional, Kumata, C., additional, Nakazawa, A., additional, Kondo, F., additional, Ono, N., additional, Koiwa, F., additional, Kinugasa, E., additional, Freisinger, W., additional, Lale, N., additional, Lampert, A., additional, Ditting, T., additional, Heinlein, S., additional, Schmieder, R. E., additional, Veelken, R., additional, Nave, H., additional, Perthel, R., additional, Suntharalingam, M., additional, Bode-Boger, S., additional, Beutel, G., additional, Kielstein, J., additional, Rodrigues-Diez, R., additional, Rayego-Mateos, S., additional, Lavoz, C., additional, Stark Aroeira, L. G., additional, Orejudo, M., additional, Alique, M., additional, Ortiz, A., additional, Egido, J., additional, Ruiz-Ortega, M., additional, Oskar, W., additional, Rusan, C., additional, Padberg, J.-S., additional, Wiesinger, A., additional, Reuter, S., additional, Grabner, A., additional, Kentrup, D., additional, Lukasz, A., additional, Oberleithner, H., additional, Pavenstadt, H., additional, Kumpers, P., additional, Eberhardt, H. U., additional, Skerka, C., additional, Chen, Q., additional, Hallstroem, T., additional, Hartmann, A., additional, Kemper, M. J., additional, Zipfel, P. F., additional, N'gome-Sendeyo, K., additional, Fan, Q.-F., additional, Toblli, J., additional, Cao, G., additional, Giani, J. F., additional, Dominici, F. P., additional, Kim, J. S., additional, Yang, J. W., additional, Kim, M. K., additional, Han, B. G., additional, and Choi, S. O., additional

Published
2012
Full Text
View/download PDF

39. Cell signalling / Pathophysiology

Author

Cerini, C., primary, Gondouin, B., additional, Dou, L., additional, Duval-Sabatier, A., additional, Brunet, P., additional, Dignat- George, F., additional, Burtey, S., additional, Okano, K., additional, Iwasaki, T., additional, Jinnai, H., additional, Hibi, A., additional, Miwa, N., additional, Kimata, N., additional, Nitta, K., additional, Akiba, T., additional, Dolley-Hitze, T., additional, Verhoest, G., additional, Jouan, F., additional, Arlot-Bonnemains, Y., additional, Lavenu, A., additional, Belaud-Rotureau, M.-A., additional, Rioux-Leclercq, N., additional, Vigneau, C., additional, Cox, S. N., additional, Sallustio, F., additional, Serino, G., additional, Loverre, A., additional, Pesce, F., additional, Gigante, M., additional, Zaza, G., additional, Stifanelli, P., additional, Ancona, N., additional, Schena, F. P., additional, Marc, P., additional, Jacques, T., additional, Green, J. M., additional, Mortensen, R. B., additional, Verma, R., additional, Leu, K., additional, Schatz, P. J., additional, Wojchowski, D. M., additional, Ihoriya, C., additional, Satoh, M., additional, Sasaki, T., additional, Kashihara, N., additional, Jung, Y. J., additional, Kang, K. P., additional, Lee, A. S., additional, Lee, J. E., additional, Lee, S., additional, Park, S. K., additional, Kim, W., additional, Florian, T., additional, Tepel, M., additional, Ying, L., additional, Katharina, K., additional, Nora, F., additional, Antje, W., additional, Alexandra, S., additional, Chiu, Y.-T., additional, Wu, M.-J., additional, Liu, Z.-H., additional, Liang, Y., additional, Zheng, C.-X., additional, Chen, Z.-H., additional, Zeng, C.-H., additional, Ranzinger, J., additional, Rustom, A., additional, Kihm, L., additional, Heide, D., additional, Scheurich, P., additional, Zeier, M., additional, Schwenger, V., additional, Liu, J., additional, Zhong, F., additional, Xu, L., additional, Zhou, Q., additional, Hao, X., additional, Wang, W., additional, Chen, N., additional, Liu, X., additional, Lu, Y., additional, Guo, S., additional, Lin, D., additional, Vilasi, A., additional, Deplano, S., additional, Cutillas, P., additional, Unwin, R., additional, Tam, F. W. K., additional, Medrano-Andres, D., additional, Lopez-Martinez, V., additional, Martinez-Miguel, P., additional, Cano, J. L., additional, Arribas, I., additional, Rodiguez-Puyol, M., additional, Lopez-Ongil, S., additional, Kadoya, H., additional, Nagasu, H., additional, Lindeberg, E., additional, Grundstrom, G., additional, Alexandra, M., additional, Ghosh, C. C., additional, David, S., additional, Mukherjee, A., additional, John, S. G., additional, Mcintyre, C. W., additional, Haller, H., additional, Parikh, S. M., additional, Troyano, N., additional, Del Nogal, M., additional, Olmos, G., additional, Mora, I., additional, DE Frutos, S., additional, Rodriguez-Puyol, M., additional, Ruiz, M. P., additional, Rothe, H., additional, Shapiro, W., additional, Ketteler, M., additional, Ramakrishnan, S. K., additional, Loupy, A., additional, Houillier, P., additional, Guilhermino Pereira, L., additional, Boim, M., additional, Aragao, D., additional, Casarini, D., additional, Jin, Y., additional, Moon, J.-Y., additional, Kim, Y.-G., additional, Lee, S.-H., additional, Lee, T.-W., additional, Ihm, C.-G., additional, Kim, E.-Y., additional, Lee, H.-J., additional, Wi, J.-G., additional, Jeong, K.-H., additional, Ruan, X. Z., additional, LI, L.-C., additional, Varghese, Z., additional, Chen, J.-B., additional, Lee, C.-T., additional, Moorhead, J., additional, Cerini, C., additional, Poitevin, S., additional, Dignat-George, F., additional, Stephane, B., additional, Bonanni, A., additional, Verzola, D., additional, Maggi, D., additional, Brunori, G., additional, Sofia, A., additional, Mannucci, I., additional, Maffioli, S., additional, Salani, B., additional, D'amato, E., additional, Saffioti, S., additional, Laudon, A., additional, Cordera, R., additional, Garibotto, G., additional, Maquigussa, E., additional, and Arnoni, C., additional

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results